Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes.
Vakrakou AG, Tzanetakos D, Valsami S, Grigoriou E, Psarra K, Tzartos J, Anagnostouli M, Andreadou E, Evangelopoulos ME, Koutsis G, Chrysovitsanou C, Gialafos E, Dimitrakopoulos A, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: koutsis g. BMC Neurol. 2018 Oct 29;18(1):178. doi: 10.1186/s12883-018-1183-4. BMC Neurol. 2018. PMID: 30373566 Free PMC article.
Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse.
Rentzos M, Nikolaou C, Rombos A, Evangelopoulos ME, Kararizou E, Koutsis G, Zoga M, Dimitrakopoulos A, Tsoutsou A, Sfangos C. Rentzos M, et al. Among authors: koutsis g. Clin Neurol Neurosurg. 2008 Dec;110(10):992-6. doi: 10.1016/j.clineuro.2008.06.005. Epub 2008 Jul 25. Clin Neurol Neurosurg. 2008. PMID: 18657352 Clinical Trial.
Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions-a single-center retrospective observational study.
Gontika M, Skarlis C, Markoglou N, Tzanetakos D, Vakrakou A, Toulas P, Koutsis G, Evangelopoulos ME, Pons R, Dardiotis E, Chrousos G, Dalakas M, Stefanis L, Anagnostouli M. Gontika M, et al. Among authors: koutsis g. Naunyn Schmiedebergs Arch Pharmacol. 2022 Aug;395(8):933-943. doi: 10.1007/s00210-022-02238-y. Epub 2022 Apr 26. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35471586
Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
Evangelopoulos ME, Andreadou E, Koutsis G, Koutoulidis V, Anagnostouli M, Katsika P, Evangelopoulos DS, Evdokimidis I, Kilidireas C. Evangelopoulos ME, et al. Among authors: koutsis g. J Neurol Sci. 2017 Jan 15;372:92-96. doi: 10.1016/j.jns.2016.11.016. Epub 2016 Nov 10. J Neurol Sci. 2017. PMID: 28017256
134 results